Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Oct 15, 2021; 13(10): 1425-1439
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1425
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1425
Figure 2 Signal pathways involved in proliferating cell nuclear antigen clamp associated factor-mediated cancers.
Proliferating cell nuclear antigen (PCNA) clamp associated factor (PCLAF) is a PCNA associated protein. Several pivotal pathways, including the Rb/E2F pathway, NF-κB pathway, and p53-p21 cascade, are implicated in PCLAF-mediated diseases. In addition, PCLAF contributes to some conditions through dysregulation of the p53 pathway, WNT signal pathway, MEK/ERK pathway, and PI3K/AKT/mTOR signal cascade (see text). Lines with an arrowhead indicate promotion, and lines with a bar indicate inhibition in steady-state or stress conditions. The distinct line colors indicate the different pathways implicated with PCLAF.
- Citation: Liu LJ, Liao JM, Zhu F. Proliferating cell nuclear antigen clamp associated factor, a potential proto-oncogene with increased expression in malignant gastrointestinal tumors. World J Gastrointest Oncol 2021; 13(10): 1425-1439
- URL: https://www.wjgnet.com/1948-5204/full/v13/i10/1425.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i10.1425